VKORC1 p.Pro147Leu

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000319788.11(VKORC1):​c.440C>T​(p.Pro147Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0114 in 1,614,136 control chromosomes in the GnomAD database, including 1,541 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 759 hom., cov: 32)
Exomes 𝑓: 0.0069 ( 782 hom. )

Consequence

VKORC1
ENST00000319788.11 missense

Scores

4
4
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.15

Publications

25 publications found
Variant links:
Genes affected
VKORC1 (HGNC:23663): (vitamin K epoxide reductase complex subunit 1) This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
VKORC1 Gene-Disease associations (from GenCC):
  • vitamin K-dependent clotting factors, combined deficiency of, type 2
    Inheritance: AR, Unknown Classification: MODERATE, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • vitamin K-dependent clotting factors, combined deficiency of, type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000319788.11, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016042292).
BP6
Variant 16-31091268-G-A is Benign according to our data. Variant chr16-31091268-G-A is described in ClinVar as Benign. ClinVar VariationId is 318975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000319788.11. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VKORC1
NM_024006.6
MANE Select
c.358C>Tp.Leu120Leu
synonymous
Exon 3 of 3NP_076869.1Q9BQB6-1
VKORC1
NM_206824.3
c.248C>Tp.Pro83Leu
missense
Exon 2 of 2NP_996560.1Q9BQB6-3
VKORC1
NM_001311311.2
c.442C>Tp.Leu148Leu
synonymous
Exon 4 of 4NP_001298240.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VKORC1
ENST00000319788.11
TSL:1
c.440C>Tp.Pro147Leu
missense
Exon 4 of 4ENSP00000326135.7Q9BQB6-2
VKORC1
ENST00000354895.4
TSL:1
c.248C>Tp.Pro83Leu
missense
Exon 2 of 2ENSP00000346969.4Q9BQB6-3
VKORC1
ENST00000394975.3
TSL:1 MANE Select
c.358C>Tp.Leu120Leu
synonymous
Exon 3 of 3ENSP00000378426.2Q9BQB6-1

Frequencies

GnomAD3 genomes
AF:
0.0553
AC:
8410
AN:
152170
Hom.:
751
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.188
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0262
Gnomad ASJ
AF:
0.00518
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00157
Gnomad OTH
AF:
0.0382
GnomAD2 exomes
AF:
0.0156
AC:
3912
AN:
251144
AF XY:
0.0119
show subpopulations
Gnomad AFR exome
AF:
0.195
Gnomad AMR exome
AF:
0.0119
Gnomad ASJ exome
AF:
0.00626
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00170
Gnomad OTH exome
AF:
0.0104
GnomAD4 exome
AF:
0.00685
AC:
10020
AN:
1461848
Hom.:
782
Cov.:
32
AF XY:
0.00615
AC XY:
4474
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.206
AC:
6882
AN:
33480
American (AMR)
AF:
0.0131
AC:
588
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00612
AC:
160
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.00101
AC:
87
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53380
Middle Eastern (MID)
AF:
0.0184
AC:
106
AN:
5768
European-Non Finnish (NFE)
AF:
0.00117
AC:
1299
AN:
1112012
Other (OTH)
AF:
0.0148
AC:
894
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
649
1299
1948
2598
3247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0554
AC:
8441
AN:
152288
Hom.:
759
Cov.:
32
AF XY:
0.0540
AC XY:
4023
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.188
AC:
7822
AN:
41542
American (AMR)
AF:
0.0261
AC:
400
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00518
AC:
18
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5176
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00157
AC:
107
AN:
68030
Other (OTH)
AF:
0.0378
AC:
80
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
351
702
1054
1405
1756
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0182
Hom.:
369
Bravo
AF:
0.0628
Asia WGS
AF:
0.0310
AC:
109
AN:
3478
EpiCase
AF:
0.00174
EpiControl
AF:
0.00249

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
Vitamin K-dependent clotting factors, combined deficiency of, type 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.017
T
BayesDel_noAF
Pathogenic
0.35
CADD
Benign
9.0
DANN
Uncertain
1.0
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.14
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.86
D
MetaRNN
Benign
0.0016
T
MetaSVM
Benign
-0.92
T
PhyloP100
2.2
PROVEAN
Benign
1.8
N
REVEL
Uncertain
0.60
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.8
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7200749;
hg19: chr16-31102589;
COSMIC: COSV54925112;
COSMIC: COSV54925112;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.